FDA Approved: CLARINEX-D 12 HOUR — Supplemental Application (Organon LLC)

View source ↗

Summary

FDA approved a supplemental application for CLARINEX-D 12 HOUR, a desloratadine and pseudoephedrine sulfate combination, from Organon LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perennial Allergic Rhinitis
• Seasonal Allergic Rhinitis

Drugs mentioned

• Desloratadine (desloratadine)
• Pseudoephedrine sulfate (pseudoephedrine sulfate)

Snippet

SUPPL AP for CLARINEX-D 12 HOUR (DESLORATADINE AND PSEUDOEPHEDRINE SULFATE)